It was a big year for US biotechs raising cash from VCs, with flush investors sinking a record-breaking $10.5 billion into new and growing companies during 2017.
{iframe}https://endpts.com/where-the-money-is-top-100-vcs-investing-in-us-biotechs-during-2017/{/iframe}